Skip to content

Study · In vitro (cells) · 1987

1 result

Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.

Serrate SA, Schulof RS, Leondaridis L, Goldstein AL, Sztein MB

Journal of immunology (Baltimore, Md. : 1950)1 Oct 1987Cited by 85 (Europe PMC)

PMID3116079 (opens in a new tab)DOI10.4049/jimmunol.139.7.2338 (opens in a new tab)PepBankPUB-03116079
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In purified human large granular lymphocytes, synthetic thymosin alpha‑1 enhanced lymphocyte activities, as thymosin fraction 5 did.

    In plain wordsIn lab tests on human immune cells, thymosin alpha‑1 increased the activity of the cells.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseLarge granular lymphocyte activities
    Study

    humann: not reported in source

    highly purified human large granular lymphocytes
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymosin-alpha 1, a synthetic polypeptide originally isolated in its native form from TF5, also exhibited enhancing effects on LGL activities
    1 context sentence
    Summary · context
    We have investigated the effects of thymosin fraction 5 (TF5) on the in vitro NK cell activity of highly purified human large granular lymphocytes (LGL).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.